Search Login Register

Xerophthalmia Summary

Description: Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.

Also Known As: Xerophthalmias

Networked: 242 relevant articles (15 outcomes, 20 trials/studies) for this Disease

Key Drugs and Agents for Xerophthalmia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Vitamin A (Retinol) : 7 outcomes 12 studies in 115 results : FDA 33 Generic
  2. Tretinoin (Retinoic Acid) : 3 outcomes in 8 results : FDA 27 Generic
  3. cevimeline (Evoxac) : 2 outcomes in 2 results : FDA 1
  4. Carbon Monoxide : 1 outcome 1 study in 3 results : IBA
  5. SS-B antibodies : 1 outcome in 2 results : IBA
  6. Muscarinic M3 Receptor : 1 outcome in 1 result : IBA
  7. Interferon-alpha (Interferon Alfa) : 1 outcome in 1 result : FDA 2
  8. Vitamin D : 1 outcome in 1 result : FDA 10 Generic
  9. Sodium Glutamate (Accent) : 1 outcome in 1 result : IBA
  10. Ivermectin (Mectizan) : 1 outcome in 1 result : FDA 1
Show All >>

Diseases Related to Xerophthalmia

  1. Xerostomia
  2. Sjogren's Syndrome (Sjogren Syndrome)
  3. Wounds and Injuries (Trauma)
  4. Vitamin A Deficiency
  5. Night Blindness (Nyctalopia)
Show All >>

Key Therapies for Xerophthalmia

Efficacy Chart >>
  1. Aftercare (After-Treatment) : 1 outcome in 3 results
  2. Oral Administration : 1 outcome in 2 results
  3. Transplantation (Transplant Recipients) : 1 study in 16 results
  4. Acupuncture Therapy : 1 study in 1 result
  5. Moxibustion : 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.